Although BPC-157 is not a dedicated weight loss peptide, some individuals may benefit from its potential recovery-supporting properties
Several GLP-1 medications are available, including Ozempic, Wegovy, Saxenda, Trulicity, Mounjaro and Zepbound
This is beneficial because they can be tailored to achieve very specific results
Understanding the physiology of natural GLP-1 provides essential context for appreciating why pharmaceutical modifications were necessary to harness its therapeutic potential for chronic disease management, particularly in type 2 diabetes and obesity treatment
It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use
Li Y, Zhang C, Cheng H, Lv L, Zhu X, Ma M, et al